On Demand 2023 Monday General Sessions
This course includes the following sessions from Monday's program:
- Plenary - Don't Be Scared of the Skin: Practical Pearls to Treat Urticaria and Atopic Dermatitis
- Evolutions in Anaphylaxis
- Inborn Errors of Immunity - Insights From the Practice Parameter Update
- WAO - World Allergy Forum - Allergen Immunotherapy Update
- Drug Allergy in Evolving Patient Care
- Supplements, Immune Boosting, Special Diets & Cannabis: What Every Allergist Needs to Know
- AACA: Updates from the Allergen Immunotherapy Primer
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 9.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medical professionals who treat patients with allergic and/or immunological conditions:
- Practicing allergist/immunologists
- Allergy/immunology Fellows-in-Training
- Physician assistants
- Nurses and advanced practice nurses
- Allied health professionals
- Primary care physicians
- Other medical professionals
Upon completion of this session, participants should be able to:
- Identify if patients with chronic urticaria need any laboratory work-up for diagnostic purposes or therapeutic response.
- Summarize available data on various therapies beyond H1-antihistamines for the treatment of chronic urticaria.
- Compare recommendations for the management of atopic dermatitis.
- Discuss how the field of primary immune deficiency or inborn errors of immunity is evolving.
- Develop a diagnostic work-up for patients presenting with possible inborn errors of immunity.
- Identify novel treatment strategies for a broad array of patients with inborn errors of immunity.
- Recognize alpha-gal syndrome in children as an explanation for cases of anaphylaxis and urticaria in Lone Star tick endemic areas.
- Understand the diagnosis of anaphylaxis, the grading of anaphylaxis symptoms, and the utilization of current and emerging biomarkers in anaphylaxis based on current clinical guidelines.
- Recognize patients with HaT and MC disorders are at increased risk of anaphylaxis.
- Demonstrate the use of current and future biologics in the prevention of anaphylaxis.
- Explain the importance of the molecular composition of the allergen extracts used in allergen immunotherapy.
- Differentiate the different types of allergen extracts available for immunotherapy.
- Clearly identify the mechanisms responsible for the beneficial effects of AIT using modified extracts, including ultra-rush updosing schemes.
- Identify the need for maintaining drug allergy de-labeling.
- Recognize the potential for telemedicine in drug allergy diagnosis and management.
- Evaluate the candidates and tools of drug desensitization.
- Analyze advantages and disadvantages of SLIT use in pediatric populations.
- Leverage rush and cluster immunotherapy with appropriate patients.
- Engage patients in successful shared decision-making processes.
- Understand how OMT manipulation practices are being used in patients with allergic disease and the evidence behind these practices.
- Review the safety considerations for natural products commonly used by patients with allergic disease.
- List the potential allergic consequences of using cannabis treatment and the evidence of cannabis use in different allergic conditions if any.
- Help their patients navigate pre, pro and post biotics and other diet practices.
Jay A. Lieberman, MD, FACAAI
Jonathan A. Bernstein, MD, FACAAI
Marc A. Riedl, MD, MS
Mark Boguniewicz, MD, FACAAI
Desiree E. Larenas-Linnemann, MD, FACAAI
Ari Heffes-Doon, MD
Jonathan Lyons, MD
Paul Turner, PhD
Kathleen R. May, MD, FACAAI
Bryan L. Martin, DO, FACAAI
Ignacio J. Ansotegui, MD, PhD
Sandra N. Gonzalez-Diaz, MD, PhD, FACAAI
Mário Morais-Almeida, MD
Caroline C. Horner, MD
Jordan S. Orange, MD, PhD, FACAAI
Javier Chinen, MD, PhD
Jennifer R. Heimall, MD, FACAAI
Sandra M. Gawchik, DO, FACAAI
Russell A. Settipane, MD, FACAAI
Michael S. Blaiss, MD, FACAAI
Justin C. Greiwe, MD, FACAAI
Don A. Bukstein, MD, FACAAI
Lawrence M. DuBuske, MD, FACAAI
Payel Gupta, MD, FACAAI
Anil Patel, MD, FACAAI
Dipa K. Sheth, MD, FACAAI, FAAAAI
Gary K. Soffer, MD
Anil Nanda, MD, FACAAI
Atoosa Kourosh, MD, MPH, FACAAI
William K. Dolen, MD, EF
Fernanda D. Young, MD
Allison C. Ramsey, MD, FACAAI
Rebecca R. Saff, MD, PhD
Mariana C. Castells, MD, PhD, FACAAI
John M. Kelso, MD, FACAAI
- 9.25 AMA PRA Category 1 Credit™
- 9.25 Attendance
- 9.25 CBRN